Searchable abstracts of presentations at key conferences in endocrinology

ea0035p79 | Bone and Osteoporosis | ECE2014

Renal aspects of primary hyperparathyroidism

Szymczak Jadwiga , Bohdanowicz-Pawlak Anna , Jakubowska Joanna

Introduction: Nephrolithiasis and bone disease are the most common complications of primary hyperparathyroidism (PHPT). The aim of this study was to evaluate the relationships between the existence of kidney stones, renal function and bone mineral density (BMD) in PHPT.Description of methods/design: Biomedical evaluation, BMD measurements and renal ultrasonography were performed in a group of 75 consecutive PHPT patients aged 57.6±12.7 years. The co...

ea0035p227 | Clinical case reports Pituitary/Adrenal | ECE2014

Meningitis coexisting with pituitary macroadenoma: report of two cases

Malicka Joanna , Kurowska Maria , Tarach Jerzy S

Background: Meningitis coexisting with pituitary macroadenoma is rarely observed. It occurs either as a primary meningitis (primary tumor manifestation), or as a secondary meningitis (after neurosurgery or reduction of the volume of the tumor which has destroyed the sellar floor or the skull base).Objective: Case reports of two patients with the concomitance of secondary meningitis and pituitary macroadenoma.Case 1: A 36-year-old m...

ea0058oc8.2 | Oral Communications 8 | BSPED2018

The effect of GnRHa treatment on bone density in young adolescents with gender dysphoria: findings from a large national cohort

Joseph Tobin , Ting Joanna , Butler Gary

Background/Aims: More young people with gender dysphoria are undergoing hormonal intervention with GnRHa treatment. The impact on bone density is not known in the very young transgender adolescents, with guidelines mentioning that Bone Mineral Density (BMD) should be monitored without a suggestion on how. This study aimed to investigate whether there were any changes in BMD or Bone Mineral Apparent Density (BMAD) whilst on GnRHa therapy.Methods: A retros...

ea0020p192 | Endocrine tumours and neoplasia | ECE2009

The comparison of serum endostatin levels between patients with metastatic and non-metastatic well differentiated thyroid cancer

Klubo-Gwiezdzinska Joanna , Roman Junik , Ewa Kopczynska

Tumor growth is limited by its neoangiogenesis, which is dependent on dynamic balance beetween it’s activators and inhibitors. One of the most important antiangiogenic factor is endostatin. Therefore we hypothesized, that serum endostatin concentration would differ between patients with metastatic and non-metastatic thyroid cancer, with multinodular goiter and healthy subjects. We also hypothesized that endogenous TSH stimulation would effect serum endostatin level.<p...

ea0016p677 | Steroid receptors | ECE2008

High level of different dietary fat modifies protein androgen receptors level in rat prostate tissues

Jablonska Olga , Gromadzka-Ostrowska Joanna , Rembiszewska Alicja

The aim of the study was to determine the effect of high-fat diets and dietary fatty acids composition on nuclear androgen receptors protein levels (AR) in rat ventral prostate epithelial and stroma part.The study was conducted on 30 male Wistar rats with initial body mass 250±10 g, divided into five groups fed four experimental and one reference diets during three weeks. Experimental semi-synthetic, high-fat (20% w/w) diets were as follows: diet A ...

ea0094p293 | Thyroid | SFEBES2023

Rebound worsening of amiodarone-induced thyrotoxicosis after discontinuation of pulse methylprednisolone despite treatment with oral steroids and thiamazole

Lewandowski Krzysztof , Kawalec Joanna , Lewinski Andrzej

Background: Amiodarone-induced thyrotoxicosis (AIT) is sometimes very difficult to treat. Pulse methylprednisolone in addition to oral steroids appears effective in treatment of AIT, but effects of such treatment may be transient.Presentation of The Case: A 65 year old man was admitted our Department because of drug-resistant AIT. He had a history of atrial fibrillation, treated with amiodarone since 2019, and NSTEMI myo...

ea0041ep335 | Clinical case reports - Thyroid/Others | ECE2016

Orbitopathy as a manifestation of Immunoglobulin-G4-related disease – case report

Zwolak Agnieszka , Dudzinska Marta , Swirska Joanna , Malicka Joanna , Daniluk Jadwiga , Tarach Jerzy S

Introduction: Immunoglobulin-G4-related disease (IgG4RD) is a multidisciplinary problem due to plasmatic cells infiltration and areas of fibrosis in the affected tissues. In IgG4RD, elevation of serum IgG4 immunoglobulins is present. Clinically, the disease is mainly manifested as: autoimmune pancreatitis, salivary gland involvement, sclerosing cholangitis, lymphadenopathy, lachrymal gland enlargement, retroperitoneal fibrosis or orbital pseudotumor. The simultaneous involveme...

ea0049ep17 | Adrenal cortex (to include Cushing's) | ECE2017

Frequancy of diabetes and prediabetes in patients with adrenal incidentaloma without hormonal activity

Bandurska-Stankiewicz Elzbieta , Myszka-Podgorska Katarzyna , Rutkowska Joanna , Matuszewski Wojciech

Aim of the study: Estimation of the frequancy of diabetes and prediabetes in patients with adrenal incidentaloma (AI) without hormonal activity.Material and methods: The study comprised patients with AI without hormonal activity, verified by CT. The hormonal function of adrenal glands was determined according to the circadian rhythm of cortisol and/or dexametasone suppression test, ACTH, aldosterone, plasma renin activity, DHEAS, androstenedione, 17hydro...

ea0049ep1226 | Paediatric endocrinology | ECE2017

Pediatric case of Autoimmune Polyglandular Syndrome type IIIC: autoimmune thyroid disease and severe autoimmune thrombocytopenia

Prokop Joanna , Leszczynska Elzbieta , Krawczuk-Rybak Maryna , Bossowski Artur

Introduction: Association between autoimmune thyroid disease (AITD) and other autoimmune disorders is common and known as autoimmune polyglandular syndrome (APS). It may involve hypoparathyoridism with Addison disease (AD) and mucocutaneous candidiasis – APS type I, AD with Diabetes mellitus type 1 (DM1) or AITD- APS type II, AITD associated with other autoimmune diseases (excluding AD): DM1- type IIIa, pernicious anemia- IIIb, or alopecia and/or vitiligo and/or other aut...

ea0041ep85 | Adrenal medulla | ECE2016

Clinical review of patients with pheochromocytoma diagnosed between 2011 and 2015

Kurowska Maria , Oszywa-Chabros Anna , Malicka Joanna , Tarach Jerzy S

Introduction: WHO classification of endocrine tumors defines pheochromocytoma as a tumor arising from chromaffin cells in the adrenal medulla. Almost all pheochromocytomas produce catecholamines. An annual incidence of this tumor in the general population is estimated at 3–8 cases/million/year. 40–50% of patients with pheochromocytoma are characterized by sustained hypertension, a similar percentage – only by paroxysmal hypertension and up to 10% are normotensiv...